Article

#2632 Quality of life and fatigue burden in individuals living with Complement 3 Glomerulopathy – a real-world study

2024-05-01

Abstract excerpt

Abstract Background and Aims C3 glomerulopathy (C3G) has an estimated incidence of 1 to 2 per million per year and is associated with a high risk of disease progression, with approximately 50% of patients reaching kidney failure within ten years of diagnosis; despite this, there are currently limited treatment options available. The impact of C3G on patient fatigue and quality of life (QoL) is well understood but...

Topics

Open a Topic to create a Post that cites this publication.

Renal Diseases and Glomerulopathies

Identifiers and source

Literature Corpus work: 3817f61b-dc93-574d-b32e-3d42cb2e7eed
DOI: 10.1093/ndt/gfae069.1313

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

#2632 Quality of life and fatigue burden in individuals living with Complement 3 Glomerulopathy – a real-world studyDOI 10.1093/ndt/gfae069.1313Read

C3 Glomerulopathy: A Current Perspective in an Evolving LandscapeSemantic proximity Read

C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.Semantic proximity Read

Prevalence, Resource Utilization and Economic Impact of Kidney Function and Proteinuria in Patients with Focal Segmental GlomerulosclerosisSemantic proximity Read

Challenges in IgA Nephropathy Management: An Era of Complement InhibitionSemantic proximity Read

Demographic, Clinical and Laboratory Characteristics of Adult-Onset Minimal Change Disease in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working GroupSemantic proximity Read

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.Semantic proximity Read

Fibrillary Glomerulonephritis: Clinicopathologic Features and OutcomesSemantic proximity Read

Economic and clinical burden in patients with primary hyperoxaluria treated with dialysis: A real- world evidence study in the United StatesSemantic proximity Read

Genotype-phenotype characteristics and disease progression of FAN1-related karyomegalic tubulointerstitial nephropathy.Semantic proximity Read

Urinary Complement proteome strongly linked to diabetic kidney disease progressionSemantic proximity Read

Safety and Effectiveness of COVID-19 Vaccines in Patients with IgA Nephropathy: A Retrospective Cohort Study from the TriNetX Global Collaborative NetworksSemantic proximity Read

Covid-19 in end-stage renal disease patients with renal replacement therapies: a systematic review and meta-analysisSemantic proximity Read